Skip to main content
. 2009 Sep 30;4(9):e7286. doi: 10.1371/journal.pone.0007286

Figure 2. Splenectomy does not alter Jak2V617F disease burden in bone marrow.

Figure 2

At the termination of the SPL-BMT study shown in Fig 1, bone marrow cells were harvested and live, GFP+ cells were analyzed by flow cytometry (A) DNA from bone marrow aspirates (B) and blood (C) was also prepared and PCR for Jak2V617F allele was performed. *p<0.01 compared to SH operated mice (nā€Š=ā€Š6 mice/group in all groups).